Viewing Study NCT06504368


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2025-12-29 @ 11:18 AM
Study NCT ID: NCT06504368
Status: RECRUITING
Last Update Posted: 2025-11-06
First Post: 2024-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module